{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:20:26Z","timestamp":1757618426516,"version":"3.44.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatologie"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s00105-025-05531-y","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T09:25:46Z","timestamp":1751275546000},"page":"483-488","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antibiotikatherapie bei sexuell \u00fcbertragbaren Infektionen","Antibiotic treatment for sexually transmitted infections"],"prefix":"10.1007","volume":"76","author":[{"given":"M.","family":"Krekels","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Potthoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,30]]},"reference":[{"key":"5531_CR1","first-page":"1","volume":"RR-03","author":"KA Workowski","year":"2015","unstructured":"Workowski\u00a0KA, Bolan\u00a0GA (2015) Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep RR-03:1\u2013137","journal-title":"MMWR Recomm Rep"},{"issue":"8","key":"5531_CR2","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1093\/cid\/civ714","volume":"61","author":"KG Ghanem","year":"2015","unstructured":"Ghanem\u00a0KG (2015) Management of Adult Syphilis: Key Questions to Inform the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines. Clin Infect Dis 61(8):818\u2013836. https:\/\/doi.org\/10.1093\/cid\/civ714","journal-title":"Clin Infect Dis"},{"key":"5531_CR3","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1111\/jdv.12734","volume":"28","author":"M Janier","year":"2014","unstructured":"Janier\u00a0M, Hegyi\u00a0V, Unemo\u00a0M et\u00a0al (2014) 2014 European guideline on the management of syphilis. J\u00a0Eur Acad Dermatol Venereol 28:1581\u20131593","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"5531_CR4","unstructured":"Deutsche STI-Gesellschaft (DSTIG) S2k-Leitlinie: Diagnostik und Therapie der Syphilis. AWMF-Registernummer 059\/002 \u2013 Stand: 06\/2021"},{"key":"5531_CR5","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1126\/science.6264606","volume":"213","author":"MV Norgard","year":"1981","unstructured":"Norgard\u00a0MV, Miller\u00a0JN (1981) Plasmid DNA in Treponema pallidum: potential for antibiotic resistance by syphilis bacteria. Science 213:535","journal-title":"Science"},{"issue":"2","key":"5531_CR6","doi-asserted-by":"publisher","first-page":"S314","DOI":"10.1093\/clinids\/7-Supplement_2.S314","volume":"7","author":"JT Stapleton","year":"1985","unstructured":"Stapleton\u00a0JT, Stamm\u00a0LV, Bassford\u00a0PJ (1985) Potential for development of antibiotic resistance in pathogenic treponemes. Rev Infect Dis 7(2):S314\u2013S317","journal-title":"Rev Infect Dis"},{"key":"5531_CR7","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1097\/OLQ.0b013e318269995f","volume":"39","author":"EG Muldoon","year":"2012","unstructured":"Muldoon\u00a0EG, Walsh\u00a0A, Crowley\u00a0B, Mulcahy\u00a0F (2012) Treponema pallidum azithromycin resistance in Dublin, Ireland. Sex Transm Dis 39:784\u2013786","journal-title":"Sex Transm Dis"},{"key":"5531_CR8","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1097\/OLQ.0b013e31826ae7a8","volume":"39","author":"M Grimes","year":"2012","unstructured":"Grimes\u00a0M, Sahi\u00a0SK, Godornes\u00a0BC, Tantalo\u00a0LC et\u00a0al (2012) Two mutations associated with macrolide resistance in Treponema pallidum: increasing prevalence and correlation with molecular strain type in Seattle, Washington. Sex Transm Dis 39:954\u2013958","journal-title":"Sex Transm Dis"},{"key":"5531_CR9","unstructured":"- S2k-Leitlinie: Infektionen mit Chlamydia trachomatis. AWMF-Registernummer 059\/005 \u2013 Stand: 08\/2016"},{"key":"5531_CR10","first-page":"254","volume":"23","author":"R Werner","year":"2025","unstructured":"Werner\u00a0R, Vader\u00a0I et\u00a0al (2025) Evidenz- und Konsensbasierte (S3) Leitlinie: Management der Urethritis bei m\u00e4nnlichen Jugendlichen und Erwachsenen. JDDG 23:254\u2013276","journal-title":"JDDG"},{"key":"5531_CR11","doi-asserted-by":"crossref","unstructured":"Regnath T, Mertes T, Ignatius R (2016) Antimicrobial resistance of Neisseria gonorrhoeae isolates in south-west Germany, 2004 to 2015: increasing minimal inhibitory concentrations of tetracycline but no resistance to third-generation cephalosporins. Euro surveillance : bulletin Europeen sur les maladies transmissibles. Eur Commun Dis Bull 21(36)","DOI":"10.2807\/1560-7917.ES.2016.21.36.30335"},{"key":"5531_CR12","first-page":"186","volume":"21","author":"S Buder","year":"2016","unstructured":"Buder\u00a0S, Guhl\u00a0E, Pf\u00fcller\u00a0R et\u00a0al (2016) Erster Nachweis einer Gonorrh\u00f6 mit einem high level Azithromycin-resistenten Erreger in Deutschland. Epid Bull 21:186\u2013187","journal-title":"Epid Bull"},{"issue":"2","key":"5531_CR13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.cmi.2023.11.006","volume":"30","author":"B B\u00ed\u017eov\u00e1","year":"2024","unstructured":"B\u00ed\u017eov\u00e1\u00a0B, Proch\u00e1zka\u00a0P, Nycov\u00e1\u00a0E et\u00a0al (2024) Single-dose cefixime 800\u202fmg plus doxycycline 100\u202fmg twice a\u00a0day for 7\u00a0days compared with single-dose ceftriaxone 1 g plus single-dose azithromycin 2 g for treatment of urogenital, rectal, and pharyngeal gonorrhoea: a\u00a0randomised clinical trial. Clin Microbiol Infect 30(2):211\u2013215","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"5531_CR14","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3201\/eid1701.100397","volume":"17","author":"M Ohnishi","year":"2011","unstructured":"Ohnishi\u00a0M, Saika\u00a0T, Hoshina\u00a0S et\u00a0al (2011) Ceftriaxone-resistant Neisseria gonorrhoeae. Japan Emerg Infect Dis 17(1):148\u2013149","journal-title":"Japan Emerg Infect Dis"},{"key":"5531_CR15","unstructured":"- S2k-Leitlinie: Diagnostik und Therapie der Gonorrhoe. AWMF Registernummer 059 \u2013 004 \u2013 Stand 12\/2018"},{"issue":"813","key":"5531_CR16","first-page":"823","volume":"75","author":"LA Vodstrcil","year":"2022","unstructured":"Vodstrcil\u00a0LA, Plummer\u00a0EL, Doyle\u00a0M et\u00a0al (2022) Combination Therapy for Mycoplasma genitalium, and New Insights Into the Utility of parC Mutant Detection to Improve Cure. Clin Infect Dis 75(813):823","journal-title":"Clin Infect Dis"},{"key":"5531_CR17","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1258\/ijsa.2008.008038","volume":"19","author":"E Jernberg","year":"2008","unstructured":"Jernberg\u00a0E, Moghaddam\u00a0A, Moi\u00a0H (2008) Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection: an open study. Int J STD AIDS 19:676\u2013679","journal-title":"Int J STD AIDS"},{"key":"5531_CR18","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1093\/cid\/cis1022","volume":"56","author":"LE Manhart","year":"2013","unstructured":"Manhart\u00a0LE, Gillespie\u00a0CW, Lowens\u00a0MS et\u00a0al (2013) Standard treatment regimens for nongonococcal urethritis have similar but declining cure rates: a\u00a0randomized controlled trial. Clin Infect Dis 56:934\u2013942","journal-title":"Clin Infect Dis"},{"key":"5531_CR19","unstructured":"Stratman S, Zampella JG (2024) Review of doxycycline for prophylaxis of sexually transmitted infection. JEADV: 1\u20138"},{"key":"5531_CR20","unstructured":"Robert Koch-Institut Gonokokken-Resistenzsurveillance (GoSurv-AMR). https:\/\/www.rki.de\/DE\/Themen\/Forschung-und-Forschungsdaten\/Sentinels-Surveillance-Panel\/Gonokokken\/gonokokken-resistenz-surveillance-node.html. Zugegriffen: 1. Apr. 2025"},{"issue":"14","key":"5531_CR21","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa2211934","volume":"388","author":"AF Luetkemeyer","year":"2023","unstructured":"Luetkemeyer\u00a0AF, Donnell\u00a0D et\u00a0al (2023) Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections. N\u00a0Engl J Med 388(14):1296\u20131306","journal-title":"N Engl J Med"}],"container-title":["Die Dermatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-025-05531-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-025-05531-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-025-05531-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T23:31:38Z","timestamp":1757201498000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-025-05531-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,30]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["5531"],"URL":"https:\/\/doi.org\/10.1007\/s00105-025-05531-y","relation":{},"ISSN":["2731-7005","2731-7013"],"issn-type":[{"type":"print","value":"2731-7005"},{"type":"electronic","value":"2731-7013"}],"subject":[],"published":{"date-parts":[[2025,6,30]]},"assertion":[{"value":"4 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.\u00a0Krekels und A.\u00a0Potthoff geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}